Sun Jae Yoo

Array ( [id] => 20722250 [patent_doc_number] => 20260138953 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-05-21 [patent_title] => CABOZANTINIB COMPOSITIONS AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 19/444948 [patent_app_country] => US [patent_app_date] => 2026-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30286 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19444948 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20518620 [patent_doc_number] => 20260042724 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-02-12 [patent_title] => 1,3-BUTYLENE GLYCOL PRODUCT [patent_app_type] => utility [patent_app_number] => 19/364623 [patent_app_country] => US [patent_app_date] => 2025-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8493 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 160 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19364623 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20452976 [patent_doc_number] => 12516026 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-01-06 [patent_title] => Cabozantinib compositions and methods of use [patent_app_type] => utility [patent_app_number] => 19/265483 [patent_app_country] => US [patent_app_date] => 2025-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 15 [patent_no_of_words] => 30321 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19265483 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20466535 [patent_doc_number] => 12522567 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-01-13 [patent_title] => Cabozantinib compositions and methods of use [patent_app_type] => utility [patent_app_number] => 19/184838 [patent_app_country] => US [patent_app_date] => 2025-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 15 [patent_no_of_words] => 30985 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 162 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19184838 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20164990 [patent_doc_number] => 20250257036 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-08-14 [patent_title] => CABOZANTINIB COMPOSITIONS AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 19/184766 [patent_app_country] => US [patent_app_date] => 2025-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30964 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 150 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19184766 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20136122 [patent_doc_number] => 20250243166 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-07-31 [patent_title] => CABOZANTINIB COMPOSITIONS AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 19/184689 [patent_app_country] => US [patent_app_date] => 2025-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30294 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 191 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19184689 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19983958 [patent_doc_number] => 20250122180 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-04-17 [patent_title] => DERIVATIVES OF SUBSTITUTED MORPHOLINES AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/999866 [patent_app_country] => US [patent_app_date] => 2024-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5395 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18999866 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20227141 [patent_doc_number] => 12415784 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-09-16 [patent_title] => Cabozantinib compositions and methods of use [patent_app_type] => utility [patent_app_number] => 18/938926 [patent_app_country] => US [patent_app_date] => 2024-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 15 [patent_no_of_words] => 31006 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18938926 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19845192 [patent_doc_number] => 20250090543 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-03-20 [patent_title] => CXCR7 INHIBITORS FOR THE TREATMENT OF CANCER [patent_app_type] => utility [patent_app_number] => 18/885326 [patent_app_country] => US [patent_app_date] => 2024-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11486 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18885326 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19656902 [patent_doc_number] => 20240423967 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-12-26 [patent_title] => PHARMACEUTICAL COMPOSITIONS COMPRISING GLITAZONES AND NRF2 ACTIVATORS [patent_app_type] => utility [patent_app_number] => 18/825022 [patent_app_country] => US [patent_app_date] => 2024-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31743 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 147 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18825022 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19769908 [patent_doc_number] => 20250051334 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-13 [patent_title] => TEBIPENEM PIVOXIL CRYSTALLINE FORMS, COMPOSITIONS INCLUDING THE SAME, METHODS OF MANUFACTURE, AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 18/823147 [patent_app_country] => US [patent_app_date] => 2024-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17229 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18823147 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20121601 [patent_doc_number] => 20250236632 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-07-24 [patent_title] => BETA-LACTAMASE INHIBITORS [patent_app_type] => utility [patent_app_number] => 18/819935 [patent_app_country] => US [patent_app_date] => 2024-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40878 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18819935 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19983972 [patent_doc_number] => 20250122194 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-04-17 [patent_title] => NOVEL SMALL MOLECULE INHIBITORS OF TEAD TRANSCRIPTION FACTORS [patent_app_type] => utility [patent_app_number] => 18/810625 [patent_app_country] => US [patent_app_date] => 2024-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 83329 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18810625 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20059164 [patent_doc_number] => 20250197386 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-06-19 [patent_title] => BENZOXAZEPIN OXAZOLIDINONE COMPOUNDS AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 18/809844 [patent_app_country] => US [patent_app_date] => 2024-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23338 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18809844 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20057334 [patent_doc_number] => 20250195556 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-06-19 [patent_title] => COMPOSITIONS, KITS, AND METHODS TO INDUCE ACQUIRED CYTORESISTANCE USING STRESS PROTEIN INDUCERS [patent_app_type] => utility [patent_app_number] => 18/797649 [patent_app_country] => US [patent_app_date] => 2024-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27325 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18797649 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19682272 [patent_doc_number] => 20250000817 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-02 [patent_title] => Methods of Treating Mitochondrial Dysfunction [patent_app_type] => utility [patent_app_number] => 18/794145 [patent_app_country] => US [patent_app_date] => 2024-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22145 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18794145 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19598703 [patent_doc_number] => 20240389583 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-28 [patent_title] => ACRYLATE DERIVATIVE, USE AND PRODUCTION INTERMEDIATE COMPOUND OF THE SAME [patent_app_type] => utility [patent_app_number] => 18/794040 [patent_app_country] => US [patent_app_date] => 2024-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40694 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18794040 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19598702 [patent_doc_number] => 20240389582 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-28 [patent_title] => ACRYLATE DERIVATIVE, USE AND PRODUCTION INTERMEDIATE COMPOUND OF THE SAME [patent_app_type] => utility [patent_app_number] => 18/794031 [patent_app_country] => US [patent_app_date] => 2024-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41455 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18794031 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20119831 [patent_doc_number] => 20250234862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-07-24 [patent_title] => FUNGICIDAL COMPOSITION FOR PREVENTING AND CONTROLLING ROOT ROT DISEASES IN CROPS CAUSED BY FUSARIUM SPP. [patent_app_type] => utility [patent_app_number] => 18/785277 [patent_app_country] => US [patent_app_date] => 2024-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 801 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18785277 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19707795 [patent_doc_number] => 20250017937 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-16 [patent_title] => MGLU2/3 ANTAGONISTS FOR THE TREATMENT OF INTELLECTUAL DISABILITIES [patent_app_type] => utility [patent_app_number] => 18/779430 [patent_app_country] => US [patent_app_date] => 2024-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7468 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -2 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18779430 [rel_patent_id] =>[rel_patent_doc_number] =>)